![](/tpixel.gif) |
Video: What is a Stock Split?
|
![](/tpixel.gif) |
Brickell Biotech is engaged in the research and development of biopharmaceutical products, including those based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Co. was focused on developing its novel antifungal VL-2397, for the treatment of patients with invasive aspergillosis. VL-2397 was being evaluated in a multicenter, open label randomized Phase 2 clinical study, designed to compare the efficacy and safety of VL-2397 to standard treatment for invasive aspergillosis in acute leukemia patients and recipients of allogeneic hematopoietic cell transplant. According to our VICL split history records, VICL has had 1 split. | |
![](/tpixel.gif) |
![VICL split history picture](/VICL-split-history.png)
VICL (VICL) has 1 split in our VICL split history database. The split for VICL took place on May 27, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of VICL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as VICL conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the VICL split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VICL shares, starting with a $10,000 purchase of VICL, presented on a split-history-adjusted basis factoring in the complete VICL split history.
![VICL split adjusted history picture](/VICL-split-adjusted-history.png)
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
01/21/2015 |
|
End date: |
08/30/2019 |
|
Start price/share: |
$10.50 |
|
End price/share: |
$0.68 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.52% |
|
Average Annual Total Return: |
-44.81% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$647.36 |
|
Years: |
4.61 |
|
|
![](/tpixel.gif) |
Date |
Ratio |
05/27/2016 | 1 for 10 |
|
![](/tpixel.gif) |